Brief: Jaguar Health Plans To Submit Investigational New Drug (Ind) Application In Q2 2023 To FDA For Crofelemer For Microvillus Inclusion Disease
27/03/2023 12:26
March 27 (Reuters) - Jaguar Health Inc JAGX.O :
* JAGUAR HEALTH INC - PLANS TO SUBMIT INVESTIGATIONAL NEW
DRUG
(IND) APPLICATION IN Q2 2023 TO FDA FOR CROFELEMER FOR
MICROVILLUS INCLUSION DISEASE
* JAGUAR HEALTH INC - FY NET LOSS PER SHARE, BASIC AND
DILUTED
$36.18
Further company coverage: JAGX.O
((Reuters.Briefs@thomsonreuters.com;))